4DMedical announced that it received FDA clearance for its XV Technology for analyzing functional lung impairment from a single X-ray.
Australia-based 4DMedical (formerly 4DX), which has a U.S. base in Woodland Hills, California, designed the XV Technology as a four-dimensional lung imaging process in the form of a software-as-a-service (Saas) diagnostic tool.
|